Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“Erythropoiesis-Stimulating Agents (ESAs) have transformed the management of anemia in chronic kidney disease and selected oncology patients by reducing transfusion requirements and improving quality of life. However, appropriate patient selection, correction of reversible causes, and careful monitoring remain essential to maximize benefit while minimizing cardiovascular and thromboembolic risks.
This evidence-based infographic summarizes:
- Indications for ESA therapy
- When to initiate treatment in CKD and dialysis
- Pre-treatment evaluation and iron optimization
- Target hemoglobin and dose adjustment
- Contraindications and adverse effects
- Causes of ESA hyporesponsiveness
- HIF-prolyl hydroxylase inhibitors and other alternatives
- Practical clinical pearls aligned with current guideline recommendations
A key reminder:
ESA therapy should be individualized – not driven by hemoglobin alone. Correct iron deficiency and other reversible causes first, use the lowest effective ESA dose to reduce transfusion needs, and avoid targeting normal hemoglobin levels. In most CKD patients, a hemoglobin around 10–11.5 g/dL is the preferred therapeutic range.
I hope this infographic serves as a concise, practical reference for residents, physicians, nephrologists, internists, and trainees involved in anemia management.”

Other posts featuring Javed Anees on Hemostasis Today.
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis
-
Nov 18, 2026, 20:55Nasir Jamal: Plasmapheresis – Key Concepts at a Glance
-
Nov 18, 2026, 20:55Tarık Seller: Pulmonary Embolism – When a Blood Clot Becomes a Life-Threatening Emergency
-
Nov 18, 2026, 20:53Sandya Arunachalam: Bringing the Profession Together at the Haemostasis and Thrombosis Workshop
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency